Bellini Federico, Allocca Valentino, Aspidistria Laura, Farinatti Marco, Guzzinati Ippolito, Daniele Marta Maria, Casanova Serena, Gasparini Francesca, Nalin Mara, Saturni Sara, Casoni Gian Luca
Respiratory Semi-Intensive Care Unit, Department of Specialistic Medicine, Ulss 5 Polesana, Rovigo, Italy.
Case Rep Pulmonol. 2025 Apr 15;2025:6371331. doi: 10.1155/crpu/6371331. eCollection 2025.
Lemierre syndrome (LS) is a rare condition with an estimated incidence of 1-10/1,000,000 per year defined as a complication of an oral and nasopharyngeal infection with secondary septicemia leading to septic emboli and internal jugular vein thrombosis. This syndrome was first described by Andre' Lemierre in 1936, before the development of antibiotics. In the preantibiotic era, it was a common condition and it was often characterized by a fatal course within 7-15 days with a mortality rate that could reach up to 80% of cases. After the development of antibiotic therapies, the incidence of LS rapidly declined, and nowadays, it is also known as "the forgotten disease," but the mortality risk remains high (5%) especially in case of diagnostic delay and inappropriate therapies. We presented a case of a 23-year-old who was referred to our hospital for worsening dyspnea associated with high fever following a pharyngitis in order to raise awareness about this severe rare disease. Long-term outcomes are usually good if proper treatment is started with no delay. The mainstays of treatment for the pulmonary and vascular aspects are antibiotic treatment with or without anticoagulation and chest-tube drainage.
勒米尔综合征(LS)是一种罕见疾病,估计年发病率为1-10/100万,定义为口腔和鼻咽部感染继发败血症导致脓毒性栓子和颈内静脉血栓形成的并发症。该综合征于1936年由安德烈·勒米尔首次描述,当时抗生素尚未问世。在抗生素出现之前的时代,它是一种常见疾病,通常表现为在7-15天内病情发展至致命,死亡率可达80%。抗生素疗法出现后,LS的发病率迅速下降,如今,它也被称为“被遗忘的疾病”,但死亡风险仍然很高(5%),尤其是在诊断延迟和治疗不当的情况下。我们报告了一例23岁患者,因咽炎后高热伴呼吸困难加重被转诊至我院,旨在提高对这种严重罕见疾病的认识。如果及时开始适当治疗,长期预后通常良好。针对肺部和血管方面的主要治疗方法是使用或不使用抗凝剂的抗生素治疗以及胸腔闭式引流。